Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study status updated to Recruiting on 2026-02-12, replacing Not yet recruiting; the record revision advanced from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check34 days agoChange DetectedReplaced the 'Last Update Posted (Estimated)' label with a plain 'Last Update Posted' label on the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and the previous v3.3.3 revision was removed.SummaryDifference0.0%

- Check69 days agoChange DetectedA consolidated 'Locations' section has been added, listing recruitment sites in Illinois (USA) and in British Columbia, Ontario, and Quebec (Canada). The previous separate 'Locations' subsections and the 'HHS Vulnerability Disclosure' link have been removed.SummaryDifference0.5%

- Check90 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, indicating a minor metadata update. There are no visible changes to study details or page content.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.